Navigation Links
Water Street Healthcare Partners Acquires OraPharma, Inc.
Date:1/5/2011

CHICAGO, Jan. 5, 2011 /PRNewswire/ -- Water Street Healthcare Partners announced today that it has acquired OraPharma, Inc. from Johnson & Johnson.  Water Street, a strategic private equity firm focused exclusively on health care, plans to build OraPharma into a leading specialty pharmaceutical company focused on dental and oral health care.  It is Water Street's latest agreement with a global health care company to acquire a business and expand its group of companies specializing in life sciences, medical devices, distribution and health care services.

OraPharma specializes in developing and distributing pharmaceutical products that maintain and restore oral health. Its main product, Arestin® (minocycline hydrochloride) is the leading locally administered antibiotic used by dentists for procedures that treat periodontitis.  Affecting more than 50 million Americans, periodontitis is the primary cause of tooth loss in adults.  OraPharma employs approximately 175 people who support thousands of dentists, hygienists, oral surgeons and periodonists across the country.  

Water Street has recruited Janet Vergis, an executive with more than 20 years of pharmaceutical experience, to serve as chief executive officer of OraPharma.  Through February 2009, Ms. Vergis served as president of Janssen Pharmaceutica -- which included responsibility for the McNeil Pediatrics and Ortho-McNeil Neurologics businesses -- a member of the Johnson & Johnson family of companies.  Previously, Ms. Vergis held positions in pharmaceutical research, new product development, sales and marketing.  

"Our goal is to build OraPharma into a leading pharmaceutical products company focused exclusively on dental and oral health.  Janet's broad pharmaceutical experience, and strong track record of growing and operating businesses make her ideally suited for this role.    We will work closely with Janet on a strategic growth plan that will invest in research and development and acquisition opportunities to expand OraPharma's portfolio of products and services to the dental health market," said Al Heller, an operating partner with Water Street and a longtime executive in the pharmaceutical industry.

OraPharma is the latest in a series of acquisitions that Water Street has completed with global health care companies.  Nearly half of Water Street's investments are business divisions it has acquired from global leaders including Gentiva Health Services, Inc., Medtronic, Inc. and Smith & Nephew.

"We are pleased that Water Street's strong track record of working with global health care leaders to acquire business divisions and transform them into successful independent  companies has led to this opportunity with OraPharma.  Water Street will leverage our team's pharmaceutical expertise and experience in corporate divestitures to build OraPharma into a market leader well-positioned to achieve long-term sustainable growth," said Peter Strothman, a principal with Water Street.

About OraPharma, Inc.

OraPharma, Inc. is a specialty pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression. ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg (www.arestin.com) is indicated as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis. For more information about OraPharma and its products, visit www.orapharma.com.

About Water Street Healthcare Partners

Water Street Healthcare Partners is a strategic private equity firm focused exclusively on health care.  The firm has a strong record of building market-leading companies across key growth sectors in health care.  It has worked with some of the world's leading health care companies on its investments including Gentiva, Medtronic and Smith & Nephew.  Water Street's team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses.  The firm is headquartered in Chicago.  For more information about Water Street, visit www.wshp.com.


'/>"/>
SOURCE Water Street Healthcare Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
2. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
3. Three Leading Sleep Solution Providers Choose Watermark Medicals Web-Enabled Home Sleep Testing Solutions
4. ARCADIS Jane Staveley to Moderate Congressional Briefing on Pharmaceuticals in Drinking Water
5. Waters Introduces Ostro Sample Preparation Products
6. Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers
7. NIST-traceable Temperature Tracking Provides Visual Alert RadarFind Sensor Now Waterproof Certified
8. VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions
9. Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC
10. Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems
11. Renhuang Appoints PricewaterhouseCoopers to Develop a SOX 404 Compliance Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
(Date:3/29/2017)... 2017 Research and Markets has announced the addition ... Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... in 2016. There are currently three proton therapy centers in ... patients. In Italy , the first patients were treated ...
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
Breaking Medicine Technology:
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
Breaking Medicine News(10 mins):